Vanderbilt-Ingram Cancer Center Archive — Page 9 of 27

Vanderbilt-Ingram website >

January 9, 2024

Chic Awearness supports mentoring program for ovarian cancer patients

Chic Awearness is now supporting two new ovarian cancer research initiatives at Vanderbilt University Medical Center and providing matching funding for a social worker to coordinate Woman to Woman, a peer mentoring program launched at VUMC in 2023.

By Tom Wilemon
January 5, 2024

Artificial intelligence advances work in VUMC’s clinical and research settings

Vanderbilt University Medical Center physicians and researchers are applying artificial intelligence in innovative ways to advance clinical care and scientific understanding of these cutting-edge tools.

By Vanderbilt Health News
January 4, 2024

VUMC in the news, Jan. 9, 2024

January 4, 2024

Potential AML therapy induces leukemic stem cell death

Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance.

By Tom Wilemon
December 20, 2023

Appointments, additions in 2023 strengthen VUMC’s core missions

During the past year, multiple new appointments and additions strengthened VUMC’s core missions.

By Vanderbilt Health News
Authors on the study included, from left, Jennifer Pietenpol, PhD, Melinda Sanders, MD, Brian Lehmann, PhD, Vandana Abramson, MD, and Yu Shyr, PhD. (photo by Donn Jones)
December 15, 2023

Clinical trial shows efficacy for atezolizumab combined with carboplatin

By Tom Wilemon